Biohaven buys PRV from GW Pharmaceuticals for USD 105 million GW Pharmaceuticals has announced its decision to sell its rare pediatric disease priority review voucher (PRV) to Biohaven Pharmaceutic...
A New Approach to treat Cystic Fibrosis Researchers at the University of Illinois in Champaign have found that anti-fungal drug amphotericin that helps lung cells to fight chronic bacterial lung infection can help in treating Cystic Fibrosis- a genetic disorder that causes serious damages to lungs. The finding ...
Find More
BioNTech lines up USD 800 Million for fuelling mRNA R&D BioNTech is lining up a Nasdaq IPO that raises USD 800 million. The German mRNA specialist is contemplating to stimulate its cash-intensive plans. BioNTech has booked Bank of America and JPMorgan with a plan to list on Nasdaq. The current plan is to inc...
Find More
Why does everyone sleep? Tired? Sleep a little. Not feeling well? Nap for a little while. Working for long? Rest a bit. For most of the things, Slumber is a solution. And now there is a scientific theory to prove that. In a recent study published in the journal Nature Communications, researchers at Bar-Ilan Uni...
Find More
Every year on 13 March, No Smoking Day encourages smokers to give up their cigarette habit. It aims to bring awareness to the dangers of this addiction. SMOKING is like committing suicide. QUIT smoking and give life a chance! Say NO to SMOKING!
Find More
Did you know that wearable technology, which consists of sports and activity trackers, accounts for nearly USD 700 Million of the healthcare industry? Moreover, analysts have assessed that the share of Wearable Devices Market is going to hit more than USD 50 Billion, by 2022. A lot of us assume that to track our st...
Find More
ColdZyme inactivates 99% of viruses causing common cold An Oral spray ColdZyme contains a solution of proteolytic enzyme trypsin and glycerol, which happens to shorten the duration of the common cold and also reduces its gravity. A recent research by Enzymatica-a Swedish based life sciences company shows the cli...
Find More
Biodesix collaborates with MRM for development of mass-spec proteomics Biodesix, the lung cancer diagnostic developer is collaborating with MRM Proteomics to authorize its iMALDI automated assay technology for quantifying proteins using mass spectrometry. It is done with the goal of enabling precision therapies....
Find More
Anti-aging startup Juvenescence raises USD 46 Million Juvenescence has bagged the USD 46 million in series B financing. The investment tees the anti-ageing startup to progress the multi-asset pipeline. Jim Mellon, a British billionaire biotech investor, created Juvenescence with early Medivation backer Greg Bai...
Find More
Apollomics raises USD 100 Million for funding of transpacific cancer R&D plan Apollomics has raised USD 100 million for funding an oncology clinical trial program. The series B round sets Apollomics to progress its c-Met inhibitor and pipeline of other clinical-phase assets. OrbiMed Asia-backed Apo...
Find More.png)
Virtual clinical trials (VCTs) are site-less clinical trials, which utilizes technology along with t.....
Find More
The convergence of technologies and the increasing integration of medical devices to computer networ.....
Find More-Feature.png)
Gastroesophageal Reflux Disease (GERD, also known as chronic acid reflux) is a digestive disorder in.....
Find More
Axial Spondyloarthritis (axSpA) is an umbrella term for a form of inflammatory form of arthritis ass.....
Find More
Asthma is a chronic disease of the air passages characterized by inflammation and narrowing of the a.....
Find More
Multiple myeloma (MM) is a cancer of the blood that begins in the bone marrow. In myeloma, plasma ce.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
